SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-019796
Filing Date
2024-07-18
Accepted
2024-07-18 20:04:01
Documents
2
Period of Report
2024-07-18

Document Format Files

Seq Description Document Type Size
1 form3-07192024_120757.html 3  
1 form3-07192024_120757.xml 3 4286
2 ex24-07192024_120757.htm EX-24 5212
  Complete submission text file 0001415889-24-019796.txt   11103
Mailing Address 2855 GAZELLE COURT C/O IONIS PHARMACEUTICALS, INC. CARLSBAD CA 92010
Business Address
HOUGEN ELIZABETH L (Reporting) CIK: 0001074773 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 0331
Type: 3 | Act: 34 | File No.: 001-42179 | Film No.: 241125803
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121
Business Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121 (858) 267-4467
Artiva Biotherapeutics, Inc. (Issuer) CIK: 0001817241 (see all company filings)

IRS No.: 863614316 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)